Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-002494

MELINTA THERAPEUTICS, INC. /NEW/ · MLNT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jan 3, 2017
Accepted (ET)
Jan 5, 2017 · 9:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461993

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stockholding———2,000D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F5$3.00Jan 3, 2017A15,000A—Jan 2, 2027Common Stock15,00015,000D
Stock Option (Right to Buy)F1$23.51holding————Dec 31, 2024Common Stock15,00015,000D
Stock Option (Right to Buy)F2$7.86holding————Jun 2, 2023Common Stock25,00025,000D
vStock Option (Right to Buy)F3$13.10holding————Jan 7, 2024Common Stock15,00015,000D
Stock Option (Right to Buy)F4$31.13holding————Dec 31, 2025Common Stock15,00015,000D

Explanation of responses